✓Sep 3 session - Last update: Sep 3, 2026, 4:48 PM ET
🛡Material / Earnings✓High confidence
Source: daily_prices:fmp_change_percent
Changes History →Market closed · Next open: Friday 9:30 AM ET
Last update: Sep 3, 2026, 6:09 PM ETMarket closed·125 changes confirmed today
Track the stock moves that actually matter.
BestStocks detects meaningful changes across price, volume, earnings, filings, valuation, analyst revisions, and risk signals — and shows you the evidence behind each one.
1,000 equities monitored14 signal typesCross-checked against SEC EDGARMedian detection lag ~41s
Investment research built around change detection.
Showing:
BestStocks identifies what changed across companies and sectors, explains why it matters, and helps investors spot opportunities worth investigating.
✓Sep 3 session - Last update: Sep 3, 2026, 4:47 PM ET
⚡Material / Earnings✓High confidence
What changed: Oscar Health, Inc. (OSCR) moved +5.19% from $30.65 to $32.24 on 2026-09-03, continuing upward momentum following its strong Q2 2026 earnings report. The company reported EPS of $1.10, beating consensus by 175%, and revenue of $4.88 billion (+70.4% year-over-year). Management raised full-year 2026 operating earnings guidance to $500–$700 million from $250–$450 million, while total membership surged 46% to 2.96 million.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
OSCR earnings scheduled for 2026-11-05; the upcoming quarter will test whether the company can sustain the membership growth and margin expansion that drove the recent guidance raise.
✓Sep 3 session - Last update: Sep 3, 2026, 4:47 PM ET
⚡Material / Earnings✓High confidence
What changed: Core Scientific, Inc. (CORZ) moved +6.48% from $16.81 to $17.90 on 2026-09-03 after securing $600 million in new senior secured credit facilities arranged with major financial institutions. The funding is intended to free up restricted cash and support the company's artificial intelligence infrastructure expansion.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Core Scientific is scheduled to report earnings on 2026-10-23 with a consensus EPS estimate of −$0.01.
✓Sep 3 session - Last update: Sep 3, 2026, 4:45 PM ET
⚡Material / Earnings✓High confidence
What changed: Sanmina Corporation (SANM) moved +5.31% on September 3, 2026, following strong fiscal third-quarter earnings and positive momentum in AI and cloud infrastructure demand. The company is benefiting from surging cloud and AI data center hardware orders, with communications networks and cloud/AI infrastructure revenues jumping significantly. ZT Systems integration is proceeding smoothly, expanding large-scale system integration capabilities, and Wall Street analysts have raised fiscal 2026 and 2027 earnings estimates. Institutional investors including Wellington Management Group and Man Group plc added to positions in early September.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Sanmina reports earnings on November 2, 2026, with consensus EPS estimate of $3.26; monitor for updates on AI infrastructure order flow and ZT Systems contribution.
✓Sep 3 session - Last update: Sep 3, 2026, 4:43 PM ET
🛡Material / Earnings✓High confidence
What changed: Charter Communications, Inc. (CHTR) moved -5.53% from $160.24 to $151.38 on 2026-09-03. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was 1.3x the 5-day average, suggesting modest institutional interest but no clear trigger for the decline.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Q3 earnings report expected 2026-10-30; consensus EPS estimate is $9.85.
✓Sep 3 session - Last update: Sep 3, 2026, 4:42 PM ET
⚡Material / Earnings✓High confidence
What changed: FTAI Aviation Ltd. (FTAI) moved +7.20% from $186.00 to $199.39 on September 3, 2026, driven by institutional positioning and sustained analyst confidence. Recent filings showed entities including the Public Employees Retirement System of Ohio establishing new positions in the company, while market sentiment remained supported by prior upbeat guidance on CFM56 engine module production and FTAI Power's data-center servicing initiative.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
FTAI Aviation earnings report on 2026-10-26 (consensus EPS estimate $1.64).
✓Sep 3 session - Last update: Sep 3, 2026, 4:41 PM ET
⚡Material / Earnings✓High confidence
What changed: CoreWeave, Inc. Class A Common Stock (CRWV) moved +5.57% from $80.10 to $84.56 on September 3, 2026, supported by optimism around AI infrastructure demand. Truist noted that Nvidia's GPU price hikes are unlikely to materially dent CoreWeave's margins, and CoreWeave's integration into Rescale's AI cloud platform reinforced confidence in its $129 billion AI backlog. Institutional buyers including Alyeska Investment Group and Sivia Capital added positions in recent 13F filings.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
CoreWeave earnings scheduled for November 9, 2026 (consensus EPS estimate: −$0.95).
✓Sep 3 session - Last update: Sep 3, 2026, 5:08 PM ET
🛡Material / Earnings✓High confidence
What changed: V.F. Corporation (VFC) moved -2.52% from $13.48 to $13.14 on 2026-09-03. We checked news, earnings announcements, analyst updates, filings, and corporate actions — no company-specific catalyst was found. Volume was modestly elevated at 1.5x the 5-day average.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Monitor V.F. Corporation's earnings announcement on 2026-10-27 for actual results versus the $0.51 consensus estimate.
✓Sep 3 session - Last update: Sep 3, 2026, 5:08 PM ET
🛡Material / Earnings✓High confidence
What changed: Conagra Brands, Inc. (CAG) moved -2.50% from $16.02 to $15.62 on September 3, 2026. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was 1.3x the 5-day average, suggesting modestly elevated trading activity.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
CAG earnings scheduled for September 30, 2026; consensus EPS estimate $0.31.
✓Sep 3 session - Last update: Sep 3, 2026, 5:08 PM ET
🛡Material / Earnings✓High confidence
What changed: MP Materials Corp. (MP) moved -2.57% from $55.20 to $53.78 on 2026-09-03. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was near its 5-day average, suggesting the move was not driven by unusual trading activity.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Monitor results on 2026-11-05 to assess whether earnings and forward guidance drive a reversal or continuation of this weakness.
✓Sep 3 session - Last update: Sep 3, 2026, 5:08 PM ET
⚡Material / Earnings✓High confidence
What changed: Knight-Swift Transportation Holdings Inc. (KNX) moved +4.57% from $66.53 to $69.57 on 2026-09-03. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was 1.4x the 5-day average, indicating modest buying interest.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Monitor for KNX earnings results on or around 2026-10-21 to assess whether recent strength has fundamental support.
✓Sep 3 session - Last update: Sep 3, 2026, 5:08 PM ET
⚡Material / Earnings✓High confidence
What changed: Raymond James Financial, Inc. (RJF) moved +2.67% from $176.39 to $181.10 on 2026-09-03. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The move occurred on volume near its 5-day average.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Raymond James Financial earnings are scheduled for 2026-10-28 (date not yet confirmed), with consensus EPS estimate of $3.38.
Latest research
View all research →In-depth equity research from the BestStocks desk — earnings breakdowns, valuation deep dives, and sector analysis behind the changes we detect.
TechnologySeptember 1, 2026 · 8 min read
Apple (AAPL) Rises as Ternus Takes Over and the Sept. 9 iPhone Event Nears
Apple rose about 2.5% to roughly $325 on September 1, and the striking part was the company it kept: on a risk-off day driven by rising Treasury yields, Apple was one of the very few large-caps to rise — Meta also gained — while Microsoft, Nvidia and Alphabet slipped alongside the Nasdaq-100. The day carried two milestones. A long-planned leadership handover took effect: John Ternus, the hardware engineer behind the iPhone and Vision Pro, became CEO, with Tim Cook — chief executive since 2011 — moving to executive chairman; the succession was announced back in April, so this was the orderly handover, not fresh news. And Apple's September 9 event, expected to unveil the iPhone 18 Pro and a first foldable, is days away. The catch is valuation: at about 36 times earnings, after a ~40% run, the stock sits right at its average analyst target and about 6% below its late-July record — and the Street is split, with a Bernstein $370 bull case against a rare Jefferies bearish call (an Underperform near $264).
AAPLRead →
IndustrialsSeptember 1, 2026 · 8 min read
Deere (DE) Hits a Record High After a Baird Upgrade on a 2027 Ag Recovery
Deere rose about 2.6% to a record high near $676 on September 1, standing out on a day technology and semiconductors sold off. The catalyst was dated and company-specific: a day earlier, Baird's Mircea Dobre upgraded Deere to Outperform and raised his price target to $800 from $640, arguing North American crop economics improve in 2027 — corn back above breakeven, better soybean margins, tighter stocks-to-use. Baird upgraded AGCO the same day, and both farm-equipment makers rose while construction bellwether Caterpillar fell, isolating an agriculture-specific move rather than a broad machinery rally. The puzzle is the valuation: Deere trades at about 36 times trailing earnings, but that reflects an expected fiscal-2026 revenue trough (down ~10% on consensus estimates), with fiscal-2027 modeled up ~8% — the recovery the upgrade is betting on. The catch: after a ~40% run to a record, the Street is split, with 11 of 24 analysts at Hold and an average target just below the price.
DERead →
HealthcareSeptember 1, 2026 · 11 min read
McKesson (MCK) Rises as a Defensive Bid Meets a $2.25B Precision Medicine Deal
McKesson rose about 2.5% to near $907 (in the upper part of its 52-week range) on September 1, standing out as technology and semiconductors sold off. The move came amid a rotation away from technology and rate-sensitive growth, as defensive areas outperformed: with the Nasdaq-100 down more than 1%, low-beta healthcare gained, and the drug distributors were among the winners — Cardinal Health and Cencora also rose. McKesson had its own tailwinds, too. On August 25 it agreed to acquire Precision Medicine Group for about $2.25 billion, folding a clinical-research and commercialization business into its fast-growing Oncology & Multispecialty segment, and it paired that with a raised outlook and a 15% dividend increase — markers of a deliberate pivot from thin-margin drug distribution into higher-value oncology and specialty services. Even so, the stock trades at about 19 times forward earnings after growing EPS more than 50% over the past year. The catch: after a ~32% run, McKesson sits near the ~$987 average analyst target, so the valuation upside has narrowed. It is a high-quality, defensively-tilted compounder the market has already discovered.
MCKRead →
ConsumerAugust 31, 2026 · 10 min read
Burlington (BURL) Stock Falls ~5% as Q3 Outlook Overshadows Q2 Beat
Burlington Stores fell about 4.8% to around $259.76 intraday on August 31, its third straight decline since the August 27 fiscal Q2 report (down ~7.6% on the 27th and ~5.9% on the 28th). The headline looked strong — reported adjusted EPS of $2.96, roughly 35% above consensus, with margin expansion and a 15th straight quarter of double-digit EPS growth — but the market looked past it. Comparable-store sales grew just 2% (down from 5% a year earlier), revenue narrowly missed at ~$3.00 billion, and Burlington guided third-quarter margins and EPS lower as it reinvests a $55 million tariff refund into customer prices. That refund also flattered the headline beat: Burlington's cleaner adjusted EPS ex-refund was $2.37 (still +38% year over year). Even though it raised full-year EPS guidance to $11.77–$11.97, a stock at ~23x earnings could not sustain a 2% comp and softer near-term margins, and Monday's leg down came as Goldman Sachs and Deutsche Bank cut targets. The move was company-specific: off-price peers Ross Stores and TJX fell less than 1% the same day. The stock is now deeply oversold (down ~31% from its high), yet 18 analysts keep a Buy consensus and a ~$365 average target.
BURLRead →
HealthcareAugust 31, 2026 · 11 min read
Cytokinetics (CYTK) Stock Falls Despite a Positive Phase 3 Aficamten Win
Cytokinetics fell about 7.5% on Friday and another ~3% Monday (to roughly $70) even though its pivotal Phase 3 ACACIA-HCM trial of aficamten met its goals in non-obstructive hypertrophic cardiomyopathy. The full data, presented at the ESC 2026 congress, hit both primary endpoints (symptoms and exercise capacity) — but the positive topline had been known since May, the stock had nearly doubled over the year, and the details disappointed: a modest effect size, two secondary endpoints that missed significance, and reduced ejection fraction (below-50% in ~10.5% of patients versus 0.8%; a known, reversible class effect). With a supplemental FDA filing not due until Q4 2026, revenue is years off, so investors sold. CYTK underperformed a soft biotech tape. Still, the Street stayed bullish: across 22 analysts, 20 rate CYTK a buy-equivalent, with an average target near $110 (about 57% above the price). Aficamten, already sold as Myqorzo for obstructive HCM, would expand into a large new patient group if the data carries through — the debate is about the details and the timeline, not whether the drug works.
CYTKRead →
TechnologyAugust 31, 2026 · 10 min read
Pinterest (PINS) Stock Falls 6% After CFO Julia Donnelly Resigns
Pinterest fell about 6% to around $21.73 on August 31 after disclosing that CFO Julia Brau Donnelly is resigning to join a private, early-stage company. She will stay until October 30 for an orderly transition, with a finance executive named interim CFO and an external search underway; the company said the exit is not due to any disagreement. Still, losing a CFO whose tenure the CEO credited with 11 straight quarters of double-digit revenue growth rattled a stock already down ~41% over the past year and trading at just ~11x forward earnings. The move was company-specific: the same day, ad peers Snap and The Trade Desk actually rose, while Meta and Alphabet fell only modestly. Analysts are constructive but split — a Buy consensus with a ~$29 average target, yet a cluster of Holds near the price — leaving the CFO exit to reopen, rather than settle, the debate over whether Pinterest's growth story holds.
PINSRead →